サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1117708

世界のアンチトロンビン市場：考察と予測 (2028年まで)

Global Antithrombin Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 129 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界のアンチトロンビン市場：考察と予測 (2028年まで)
出版日: 2022年08月23日
発行: QYResearch
ページ情報: 英文 129 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、アンチトロンビン (Antithrombin) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • アンチトロンビンの製品概要
  • 市場：タイプ別
    • 世界のアンチトロンビンの市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Liquid
    • Lyophilized
  • 市場：アプリケーション別
    • 世界のアンチトロンビンの市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Diagnostics
    • Therapeutics
    • Research
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のアンチトロンビンの販売 推定および予測 2017-2028
  • 世界のアンチトロンビンの収益 推定および予測 2017-2028
  • 世界のアンチトロンビンの収益：地域別: 2017 VS 2021 VS 2028
  • 世界のアンチトロンビンの販売：地域別
    • 世界のアンチトロンビンの販売：地域別 (2017-2022)
    • 世界の販売 アンチトロンビン ：地域別 (2023-2028)
  • 世界のアンチトロンビンの収益：地域別
    • 世界のアンチトロンビンの収益：地域別 (2017-2022)
    • 世界のアンチトロンビンの収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界のアンチトロンビンの販売：メーカー別
    • 世界のアンチトロンビンの上位メーカー：販売別 (2017-2022)
    • 世界のアンチトロンビンの販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： アンチトロンビン2021
  • 世界のアンチトロンビンの収益：メーカー別
    • 世界のアンチトロンビンの収益：メーカー別 (2017-2022)
    • 世界のアンチトロンビンの収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： アンチトロンビンの収益 2021
  • 世界のアンチトロンビンの販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のアンチトロンビンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のアンチトロンビンのメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界のアンチトロンビンの販売：タイプ別
    • 世界のアンチトロンビンの販売実績：タイプ別 (2017-2022)
    • 世界のアンチトロンビンの販売予測：タイプ別 (2023-2028)
    • 世界のアンチトロンビンの販売市場シェア：タイプ別 (2017-2028)
  • 世界のアンチトロンビンの収益：タイプ別
    • 世界のアンチトロンビンの収益実績：タイプ別 (2017-2022)
    • 世界のアンチトロンビンの収益予測：タイプ別 (2023-2028)
    • 世界のアンチトロンビンの収益市場シェア：タイプ別 (2017-2028)
  • 世界のアンチトロンビンの価格：タイプ別
    • 世界のアンチトロンビンの価格：タイプ別 (2017-2022)
    • 世界のアンチトロンビンの価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界のアンチトロンビンの販売：アプリケーション別
    • 世界のアンチトロンビンの販売実績：アプリケーション別 (2017-2022)
    • 世界のアンチトロンビンの販売予測：アプリケーション別 (2023-2028)
    • 世界のアンチトロンビンの販売市場シェア：アプリケーション別 (2017-2028)
  • 世界のアンチトロンビンの収益：アプリケーション別
    • 世界のアンチトロンビンの収益実績：アプリケーション別 (2017-2022)
    • 世界のアンチトロンビンの収益予測：アプリケーション別 (2023-2028)
    • 世界のアンチトロンビンの収益市場シェア：アプリケーション別 (2017-2028)
  • 世界のアンチトロンビンの価格：アプリケーション別
    • 世界のアンチトロンビンの価格：アプリケーション別 (2017-2022)
    • 世界のアンチトロンビンの価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米のアンチトロンビン 市場規模：タイプ別
    • 北米のアンチトロンビンの販売：タイプ別 (2017-2028)
    • 北米のアンチトロンビンの収益：タイプ別 (2017-2028)
  • 北米のアンチトロンビン 市場規模：アプリケーション別
    • 北米のアンチトロンビンの販売：アプリケーション別 (2017-2028)
    • 北米のアンチトロンビンの収益：アプリケーション別 (2017-2028)
  • 北米のアンチトロンビン 市場規模：国別
    • 北米のアンチトロンビンの販売：国別 (2017-2028)
    • 北米のアンチトロンビンの収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のアンチトロンビン 市場規模：タイプ別
    • 欧州のアンチトロンビンの販売：タイプ別 (2017-2028)
    • 欧州のアンチトロンビンの収益：タイプ別 (2017-2028)
  • 欧州のアンチトロンビン 市場規模：アプリケーション別
    • 欧州のアンチトロンビンの販売：アプリケーション別 (2017-2028)
    • 欧州のアンチトロンビンの収益：アプリケーション別 (2017-2028)
  • 欧州のアンチトロンビン 市場規模：国別
    • 欧州のアンチトロンビンの販売：国別 (2017-2028)
    • 欧州のアンチトロンビンの収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のアンチトロンビン 市場規模：タイプ別
    • アジア太平洋のアンチトロンビンの販売：タイプ別 (2017-2028)
    • アジア太平洋のアンチトロンビンの収益：タイプ別 (2017-2028)
  • アジア太平洋のアンチトロンビン 市場規模：アプリケーション別
    • アジア太平洋のアンチトロンビンの販売：アプリケーション別 (2017-2028)
    • アジア太平洋のアンチトロンビンの収益：アプリケーション別 (2017-2028)
  • アジア太平洋のアンチトロンビン 市場規模：地域別
    • アジア太平洋のアンチトロンビンの販売：地域別 (2017-2028)
    • アジア太平洋のアンチトロンビンの収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第9章 ラテンアメリカ

  • ラテンアメリカのアンチトロンビン 市場規模：タイプ別
    • ラテンアメリカのアンチトロンビンの販売：タイプ別 (2017-2028)
    • ラテンアメリカのアンチトロンビンの収益：タイプ別 (2017-2028)
  • ラテンアメリカのアンチトロンビン 市場規模：アプリケーション別
    • ラテンアメリカのアンチトロンビンの販売：アプリケーション別 (2017-2028)
    • ラテンアメリカのアンチトロンビンの収益：アプリケーション別 (2017-2028)
  • ラテンアメリカのアンチトロンビン 市場規模：国別
    • ラテンアメリカのアンチトロンビンの販売：国別 (2017-2028)
    • ラテンアメリカのアンチトロンビンの収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカのアンチトロンビン 市場規模：タイプ別
    • 中東・アフリカのアンチトロンビンの販売：タイプ別 (2017-2028)
    • 中東・アフリカのアンチトロンビンの収益：タイプ別 (2017-2028)
  • 中東・アフリカのアンチトロンビン 市場規模：アプリケーション別
    • 中東・アフリカのアンチトロンビンの販売：アプリケーション別 (2017-2028)
    • 中東・アフリカのアンチトロンビンの収益：アプリケーション別 (2017-2028)
  • 中東・アフリカのアンチトロンビン 市場規模：国別
    • 中東・アフリカのアンチトロンビンの販売：国別 (2017-2028)
    • 中東・アフリカのアンチトロンビンの収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • Grifols
  • rEVO Biologics Inc.
  • Takeda
  • Kedrion S.p.A.
  • CSL Limited
  • Scripps Laboratories Inc.
  • Lee Biosolutions

第12章 業界チェーンと販売チャネルの分析

  • アンチトロンビン 業界チェーン分析
  • アンチトロンビン 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • アンチトロンビン 生産形態とプロセス
  • アンチトロンビン 販売およびマーケティング
    • アンチトロンビン 販売チャネル
    • アンチトロンビン 卸業者
  • アンチトロンビン 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • アンチトロンビン 業界動向
  • アンチトロンビン 市場の促進要因
  • アンチトロンビン 市場の課題
  • アンチトロンビン 市場の抑制要因

第14章 世界のアンチトロンビンの主な市場調査結果

第15章 付録

図表
  • Table 1. Global Antithrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Liquid
  • Table 3. Major Manufacturers of Lyophilized
  • Table 4. Global Antithrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 5. Global Antithrombin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Antithrombin Sales by Region (2017-2022) & (Units)
  • Table 7. Global Antithrombin Sales Market Share by Region (2017-2022)
  • Table 8. Global Antithrombin Sales by Region (2023-2028) & (Units)
  • Table 9. Global Antithrombin Sales Market Share by Region (2023-2028)
  • Table 10. Global Antithrombin Revenue by Region (2017-2022) & (US$ Million)
  • Table 11. Global Antithrombin Revenue Market Share by Region (2017-2022)
  • Table 12. Global Antithrombin Revenue by Region (2023-2028) & (US$ Million)
  • Table 13. Global Antithrombin Revenue Market Share by Region (2023-2028)
  • Table 14. Global Antithrombin Sales by Manufacturers (2017-2022) & (Units)
  • Table 15. Global Antithrombin Sales Share by Manufacturers (2017-2022)
  • Table 16. Global Antithrombin Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 17. Global Antithrombin Revenue Share by Manufacturers (2017-2022)
  • Table 18. Antithrombin Price by Manufacturers (2017-2022) &(US$/Unit)
  • Table 19. Global Antithrombin Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 20. Global Antithrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin as of 2021)
  • Table 21. Antithrombin Manufacturing Base Distribution and Headquarters
  • Table 22. Manufacturers Antithrombin Product Offered
  • Table 23. Date of Manufacturers Enter into Antithrombin Market
  • Table 24. Mergers & Acquisitions, Expansion Plans
  • Table 25. Global Antithrombin Sales by Type (2017-2022) & (Units)
  • Table 26. Global Antithrombin Sales by Type (2023-2028) & (Units)
  • Table 27. Global Antithrombin Sales Share by Type (2017-2022)
  • Table 28. Global Antithrombin Sales Share by Type (2023-2028)
  • Table 29. Global Antithrombin Revenue by Type (2017-2022) & (US$ Million)
  • Table 30. Global Antithrombin Revenue by Type (2023-2028) & (US$ Million)
  • Table 31. Global Antithrombin Revenue Share by Type (2017-2022)
  • Table 32. Global Antithrombin Revenue Share by Type (2023-2028)
  • Table 33. Antithrombin Price by Type (2017-2022) & (US$/Unit)
  • Table 34. Global Antithrombin Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 35. Global Antithrombin Sales by Application (2017-2022) & (Units)
  • Table 36. Global Antithrombin Sales by Application (2023-2028) & (Units)
  • Table 37. Global Antithrombin Sales Share by Application (2017-2022)
  • Table 38. Global Antithrombin Sales Share by Application (2023-2028)
  • Table 39. Global Antithrombin Revenue by Application (2017-2022) & (US$ Million)
  • Table 40. Global Antithrombin Revenue by Application (2023-2028) & (US$ Million)
  • Table 41. Global Antithrombin Revenue Share by Application (2017-2022)
  • Table 42. Global Antithrombin Revenue Share by Application (2023-2028)
  • Table 43. Antithrombin Price by Application (2017-2022) & (US$/Unit)
  • Table 44. Global Antithrombin Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 45. North America Antithrombin Sales by Type (2017-2022) & (Units)
  • Table 46. North America Antithrombin Sales by Type (2023-2028) & (Units)
  • Table 47. North America Antithrombin Revenue by Type (2017-2022) & (US$ Million)
  • Table 48. North America Antithrombin Revenue by Type (2023-2028) & (US$ Million)
  • Table 49. North America Antithrombin Sales by Application (2017-2022) & (Units)
  • Table 50. North America Antithrombin Sales by Application (2023-2028) & (Units)
  • Table 51. North America Antithrombin Revenue by Application (2017-2022) & (US$ Million)
  • Table 52. North America Antithrombin Revenue by Application (2023-2028) & (US$ Million)
  • Table 53. North America Antithrombin Sales by Country (2017-2022) & (Units)
  • Table 54. North America Antithrombin Sales by Country (2023-2028) & (Units)
  • Table 55. North America Antithrombin Revenue by Country (2017-2022) & (US$ Million)
  • Table 56. North America Antithrombin Revenue by Country (2023-2028) & (US$ Million)
  • Table 57. Europe Antithrombin Sales by Type (2017-2022) & (Units)
  • Table 58. Europe Antithrombin Sales by Type (2023-2028) & (Units)
  • Table 59. Europe Antithrombin Revenue by Type (2017-2022) & (US$ Million)
  • Table 60. Europe Antithrombin Revenue by Type (2023-2028) & (US$ Million)
  • Table 61. Europe Antithrombin Sales by Application (2017-2022) & (Units)
  • Table 62. Europe Antithrombin Sales by Application (2023-2028) & (Units)
  • Table 63. Europe Antithrombin Revenue by Application (2017-2022) & (US$ Million)
  • Table 64. Europe Antithrombin Revenue by Application (2023-2028) & (US$ Million)
  • Table 65. Europe Antithrombin Sales by Country (2017-2022) & (Units)
  • Table 66. Europe Antithrombin Sales by Country (2023-2028) & (Units)
  • Table 67. Europe Antithrombin Revenue by Country (2017-2022) & (US$ Million)
  • Table 68. Europe Antithrombin Revenue by Country (2023-2028) & (US$ Million)
  • Table 69. Asia Pacific Antithrombin Sales by Type (2017-2022) & (Units)
  • Table 70. Asia Pacific Antithrombin Sales by Type (2023-2028) & (Units)
  • Table 71. Asia Pacific Antithrombin Revenue by Type (2017-2022) & (US$ Million)
  • Table 72. Asia Pacific Antithrombin Revenue by Type (2023-2028) & (US$ Million)
  • Table 73. Asia Pacific Antithrombin Sales by Application (2017-2022) & (Units)
  • Table 74. Asia Pacific Antithrombin Sales by Application (2023-2028) & (Units)
  • Table 75. Asia Pacific Antithrombin Revenue by Application (2017-2022) & (US$ Million)
  • Table 76. Asia Pacific Antithrombin Revenue by Application (2023-2028) & (US$ Million)
  • Table 77. Asia Pacific Antithrombin Sales by Region (2017-2022) & (Units)
  • Table 78. Asia Pacific Antithrombin Sales by Region (2023-2028) & (Units)
  • Table 79. Asia Pacific Antithrombin Revenue by Region (2017-2022) & (US$ Million)
  • Table 80. Asia Pacific Antithrombin Revenue by Region (2023-2028) & (US$ Million)
  • Table 81. Latin America Antithrombin Sales by Type (2017-2022) & (Units)
  • Table 82. Latin America Antithrombin Sales by Type (2023-2028) & (Units)
  • Table 83. Latin America Antithrombin Revenue by Type (2017-2022) & (US$ Million)
  • Table 84. Latin America Antithrombin Revenue by Type (2023-2028) & (US$ Million)
  • Table 85. Latin America Antithrombin Sales by Application (2017-2022) & (Units)
  • Table 86. Latin America Antithrombin Sales by Application (2023-2028) & (Units)
  • Table 87. Latin America Antithrombin Revenue by Application (2017-2022) & (US$ Million)
  • Table 88. Latin America Antithrombin Revenue by Application (2023-2028) & (US$ Million)
  • Table 89. Latin America Antithrombin Sales by Country (2017-2022) & (Units)
  • Table 90. Latin America Antithrombin Sales by Country (2023-2028) & (Units)
  • Table 91. Latin America Antithrombin Revenue by Country (2017-2022) & (US$ Million)
  • Table 92. Latin America Antithrombin Revenue by Country (2023-2028) & (US$ Million)
  • Table 93. Middle East and Africa Antithrombin Sales by Type (2017-2022) & (Units)
  • Table 94. Middle East and Africa Antithrombin Sales by Type (2023-2028) & (Units)
  • Table 95. Middle East and Africa Antithrombin Revenue by Type (2017-2022) & (US$ Million)
  • Table 96. Middle East and Africa Antithrombin Revenue by Type (2023-2028) & (US$ Million)
  • Table 97. Middle East and Africa Antithrombin Sales by Application (2017-2022) & (Units)
  • Table 98. Middle East and Africa Antithrombin Sales by Application (2023-2028) & (Units)
  • Table 99. Middle East and Africa Antithrombin Revenue by Application (2017-2022) & (US$ Million)
  • Table 100. Middle East and Africa Antithrombin Revenue by Application (2023-2028) & (US$ Million)
  • Table 101. Middle East and Africa Antithrombin Sales by Country (2017-2022) & (Units)
  • Table 102. Middle East and Africa Antithrombin Sales by Country (2023-2028) & (Units)
  • Table 103. Middle East and Africa Antithrombin Revenue by Country (2017-2022) & (US$ Million)
  • Table 104. Middle East and Africa Antithrombin Revenue by Country (2023-2028) & (US$ Million)
  • Table 105. Grifols Corporation Information
  • Table 106. Grifols Description and Major Businesses
  • Table 107. Grifols Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 108. Grifols Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 109. Grifols Recent Developments
  • Table 110. rEVO Biologics Inc. Corporation Information
  • Table 111. rEVO Biologics Inc. Description and Major Businesses
  • Table 112. rEVO Biologics Inc. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 113. rEVO Biologics Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 114. rEVO Biologics Inc. Recent Developments
  • Table 115. Takeda Corporation Information
  • Table 116. Takeda Description and Major Businesses
  • Table 117. Takeda Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 118. Takeda Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 119. Takeda Recent Developments
  • Table 120. Kedrion S.p.A. Corporation Information
  • Table 121. Kedrion S.p.A. Description and Major Businesses
  • Table 122. Kedrion S.p.A. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 123. Kedrion S.p.A. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 124. Kedrion S.p.A. Recent Developments
  • Table 125. CSL Limited Corporation Information
  • Table 126. CSL Limited Description and Major Businesses
  • Table 127. CSL Limited Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 128. CSL Limited Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 129. CSL Limited Recent Developments
  • Table 130. Scripps Laboratories Inc. Corporation Information
  • Table 131. Scripps Laboratories Inc. Description and Major Businesses
  • Table 132. Scripps Laboratories Inc. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 133. Scripps Laboratories Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Scripps Laboratories Inc. Recent Developments
  • Table 135. Lee Biosolutions Corporation Information
  • Table 136. Lee Biosolutions Description and Major Businesses
  • Table 137. Lee Biosolutions Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 138. Lee Biosolutions Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 139. Lee Biosolutions Recent Developments
  • Table 140. Key Raw Materials Lists
  • Table 141. Raw Materials Key Suppliers Lists
  • Table 142. Antithrombin Distributors List
  • Table 143. Antithrombin Customers List
  • Table 144. Antithrombin Market Trends
  • Table 145. Antithrombin Market Drivers
  • Table 146. Antithrombin Market Challenges
  • Table 147. Antithrombin Market Restraints
  • Table 148. Research Programs/Design for This Report
  • Table 149. Key Data Information from Secondary Sources
  • Table 150. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Antithrombin Product Picture
  • Figure 3. Global Antithrombin Market Share by Type in 2021 & 2028
  • Figure 3. Liquid Product Picture
  • Figure 4. Lyophilized Product Picture
  • Figure 5. Global Antithrombin Market Share by Application in 2021 & 2028
  • Figure 6. Diagnostics
  • Figure 7. Therapeutics
  • Figure 8. Research
  • Figure 9. Antithrombin Report Years Considered
  • Figure 10. Global Antithrombin Sales 2017-2028 (Units)
  • Figure 11. Global Antithrombin Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Antithrombin Revenue 2017-2028 (US$ Million)
  • Figure 13. Global Antithrombin Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 14. Global Antithrombin Sales Market Share by Region (2017-2022)
  • Figure 15. Global Antithrombin Sales Market Share by Region (2023-2028)
  • Figure 16. North America Antithrombin Sales YoY (2017-2028) & (Units)
  • Figure 17. North America Antithrombin Revenue YoY (2017-2028) & (US$ Million)
  • Figure 18. Europe Antithrombin Sales YoY (2017-2028) & (Units)
  • Figure 19. Europe Antithrombin Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Asia-Pacific Antithrombin Sales YoY (2017-2028) & (Units)
  • Figure 21. Asia-Pacific Antithrombin Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Latin America Antithrombin Sales YoY (2017-2028) & (Units)
  • Figure 23. Latin America Antithrombin Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Middle East & Africa Antithrombin Sales YoY (2017-2028) & (Units)
  • Figure 25. Middle East & Africa Antithrombin Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. The Antithrombin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 27. The Top 5 and 10 Largest Manufacturers of Antithrombin in the World: Market Share by Antithrombin Revenue in 2021
  • Figure 28. Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 29. Global Antithrombin Sales Market Share by Type (2017-2028)
  • Figure 30. Global Antithrombin Revenue Market Share by Type (2017-2028)
  • Figure 31. Global Antithrombin Sales Market Share by Application (2017-2028)
  • Figure 32. Global Antithrombin Revenue Market Share by Application (2017-2028)
  • Figure 33. North America Antithrombin Sales Market Share by Type (2017-2028)
  • Figure 34. North America Antithrombin Revenue Market Share by Type (2017-2028)
  • Figure 35. North America Antithrombin Sales Market Share by Application (2017-2028)
  • Figure 36. North America Antithrombin Revenue Market Share by Application (2017-2028)
  • Figure 37. North America Antithrombin Sales Share by Country (2017-2028)
  • Figure 38. North America Antithrombin Revenue Share by Country (2017-2028)
  • Figure 39. U.S. Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 40. Canada Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 41. Europe Antithrombin Sales Market Share by Type (2017-2028)
  • Figure 42. Europe Antithrombin Revenue Market Share by Type (2017-2028)
  • Figure 43. Europe Antithrombin Sales Market Share by Application (2017-2028)
  • Figure 44. Europe Antithrombin Revenue Market Share by Application (2017-2028)
  • Figure 45. Europe Antithrombin Sales Share by Country (2017-2028)
  • Figure 46. Europe Antithrombin Revenue Share by Country (2017-2028)
  • Figure 47. Germany Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 48. France Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 49. U.K. Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 50. Italy Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 51. Russia Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 52. Asia Pacific Antithrombin Sales Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific Antithrombin Revenue Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific Antithrombin Sales Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific Antithrombin Revenue Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific Antithrombin Sales Share by Region (2017-2028)
  • Figure 57. Asia Pacific Antithrombin Revenue Share by Region (2017-2028)
  • Figure 58. China Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 59. Japan Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 60. South Korea Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 61. India Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 62. Australia Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 63. Taiwan Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 64. Indonesia Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 65. Thailand Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 66. Malaysia Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 67. Philippines Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 68. Latin America Antithrombin Sales Market Share by Type (2017-2028)
  • Figure 69. Latin America Antithrombin Revenue Market Share by Type (2017-2028)
  • Figure 70. Latin America Antithrombin Sales Market Share by Application (2017-2028)
  • Figure 71. Latin America Antithrombin Revenue Market Share by Application (2017-2028)
  • Figure 72. Latin America Antithrombin Sales Share by Country (2017-2028)
  • Figure 73. Latin America Antithrombin Revenue Share by Country (2017-2028)
  • Figure 74. Mexico Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 75. Brazil Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 76. Argentina Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 77. Middle East and Africa Antithrombin Sales Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Antithrombin Revenue Market Share by Type (2017-2028)
  • Figure 79. Middle East and Africa Antithrombin Sales Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Antithrombin Revenue Market Share by Application (2017-2028)
  • Figure 81. Middle East and Africa Antithrombin Sales Share by Country (2017-2028)
  • Figure 82. Middle East and Africa Antithrombin Revenue Share by Country (2017-2028)
  • Figure 83. Turkey Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 84. Saudi Arabia Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 85. UAE Antithrombin Revenue (2017-2028) & (US$ Million)
  • Figure 86. Antithrombin Value Chain
  • Figure 87. Antithrombin Production Process
  • Figure 88. Channels of Distribution
  • Figure 89. Distributors Profiles
  • Figure 90. Bottom-up and Top-down Approaches for This Report
  • Figure 91. Data Triangulation
  • Figure 92. Key Executives Interviewed
目次

This research report focuses on the Antithrombin Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Antithrombin Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Antithrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Liquid
    • 1.2.3 Lyophilized
  • 1.3 Market by Application
    • 1.3.1 Global Antithrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Diagnostics
    • 1.3.3 Therapeutics
    • 1.3.4 Research
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Antithrombin Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Antithrombin Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Antithrombin Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Antithrombin Sales by Region
    • 2.4.1 Global Antithrombin Sales by Region (2017-2022)
    • 2.4.2 Global Sales Antithrombin by Region (2023-2028)
  • 2.5 Global Antithrombin Revenue by Region
    • 2.5.1 Global Antithrombin Revenue by Region (2017-2022)
    • 2.5.2 Global Antithrombin Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Antithrombin Sales by Manufacturers
    • 3.1.1 Global Top Antithrombin Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Antithrombin Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antithrombin in 2021
  • 3.2 Global Antithrombin Revenue by Manufacturers
    • 3.2.1 Global Antithrombin Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Antithrombin Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Antithrombin Revenue in 2021
  • 3.3 Global Antithrombin Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Antithrombin Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Antithrombin Sales by Type
    • 4.1.1 Global Antithrombin Historical Sales by Type (2017-2022)
    • 4.1.2 Global Antithrombin Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Antithrombin Sales Market Share by Type (2017-2028)
  • 4.2 Global Antithrombin Revenue by Type
    • 4.2.1 Global Antithrombin Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Antithrombin Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Antithrombin Revenue Market Share by Type (2017-2028)
  • 4.3 Global Antithrombin Price by Type
    • 4.3.1 Global Antithrombin Price by Type (2017-2022)
    • 4.3.2 Global Antithrombin Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Antithrombin Sales by Application
    • 5.1.1 Global Antithrombin Historical Sales by Application (2017-2022)
    • 5.1.2 Global Antithrombin Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Antithrombin Sales Market Share by Application (2017-2028)
  • 5.2 Global Antithrombin Revenue by Application
    • 5.2.1 Global Antithrombin Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Antithrombin Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Antithrombin Revenue Market Share by Application (2017-2028)
  • 5.3 Global Antithrombin Price by Application
    • 5.3.1 Global Antithrombin Price by Application (2017-2022)
    • 5.3.2 Global Antithrombin Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Antithrombin Market Size by Type
    • 6.1.1 North America Antithrombin Sales by Type (2017-2028)
    • 6.1.2 North America Antithrombin Revenue by Type (2017-2028)
  • 6.2 North America Antithrombin Market Size by Application
    • 6.2.1 North America Antithrombin Sales by Application (2017-2028)
    • 6.2.2 North America Antithrombin Revenue by Application (2017-2028)
  • 6.3 North America Antithrombin Market Size by Country
    • 6.3.1 North America Antithrombin Sales by Country (2017-2028)
    • 6.3.2 North America Antithrombin Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Antithrombin Market Size by Type
    • 7.1.1 Europe Antithrombin Sales by Type (2017-2028)
    • 7.1.2 Europe Antithrombin Revenue by Type (2017-2028)
  • 7.2 Europe Antithrombin Market Size by Application
    • 7.2.1 Europe Antithrombin Sales by Application (2017-2028)
    • 7.2.2 Europe Antithrombin Revenue by Application (2017-2028)
  • 7.3 Europe Antithrombin Market Size by Country
    • 7.3.1 Europe Antithrombin Sales by Country (2017-2028)
    • 7.3.2 Europe Antithrombin Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Antithrombin Market Size by Type
    • 8.1.1 Asia Pacific Antithrombin Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Antithrombin Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Antithrombin Market Size by Application
    • 8.2.1 Asia Pacific Antithrombin Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Antithrombin Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Antithrombin Market Size by Region
    • 8.3.1 Asia Pacific Antithrombin Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Antithrombin Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Antithrombin Market Size by Type
    • 9.1.1 Latin America Antithrombin Sales by Type (2017-2028)
    • 9.1.2 Latin America Antithrombin Revenue by Type (2017-2028)
  • 9.2 Latin America Antithrombin Market Size by Application
    • 9.2.1 Latin America Antithrombin Sales by Application (2017-2028)
    • 9.2.2 Latin America Antithrombin Revenue by Application (2017-2028)
  • 9.3 Latin America Antithrombin Market Size by Country
    • 9.3.1 Latin America Antithrombin Sales by Country (2017-2028)
    • 9.3.2 Latin America Antithrombin Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Antithrombin Market Size by Type
    • 10.1.1 Middle East and Africa Antithrombin Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Antithrombin Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Antithrombin Market Size by Application
    • 10.2.1 Middle East and Africa Antithrombin Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Antithrombin Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Antithrombin Market Size by Country
    • 10.3.1 Middle East and Africa Antithrombin Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Antithrombin Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Grifols
    • 11.1.1 Grifols Corporation Information
    • 11.1.2 Grifols Overview
    • 11.1.3 Grifols Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Grifols Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Grifols Recent Developments
  • 11.2 rEVO Biologics Inc.
    • 11.2.1 rEVO Biologics Inc. Corporation Information
    • 11.2.2 rEVO Biologics Inc. Overview
    • 11.2.3 rEVO Biologics Inc. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 rEVO Biologics Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 rEVO Biologics Inc. Recent Developments
  • 11.3 Takeda
    • 11.3.1 Takeda Corporation Information
    • 11.3.2 Takeda Overview
    • 11.3.3 Takeda Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Takeda Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Takeda Recent Developments
  • 11.4 Kedrion S.p.A.
    • 11.4.1 Kedrion S.p.A. Corporation Information
    • 11.4.2 Kedrion S.p.A. Overview
    • 11.4.3 Kedrion S.p.A. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Kedrion S.p.A. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Kedrion S.p.A. Recent Developments
  • 11.5 CSL Limited
    • 11.5.1 CSL Limited Corporation Information
    • 11.5.2 CSL Limited Overview
    • 11.5.3 CSL Limited Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 CSL Limited Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 CSL Limited Recent Developments
  • 11.6 Scripps Laboratories Inc.
    • 11.6.1 Scripps Laboratories Inc. Corporation Information
    • 11.6.2 Scripps Laboratories Inc. Overview
    • 11.6.3 Scripps Laboratories Inc. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Scripps Laboratories Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Scripps Laboratories Inc. Recent Developments
  • 11.7 Lee Biosolutions
    • 11.7.1 Lee Biosolutions Corporation Information
    • 11.7.2 Lee Biosolutions Overview
    • 11.7.3 Lee Biosolutions Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Lee Biosolutions Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Lee Biosolutions Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Antithrombin Industry Chain Analysis
  • 12.2 Antithrombin Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Antithrombin Production Mode & Process
  • 12.4 Antithrombin Sales and Marketing
    • 12.4.1 Antithrombin Sales Channels
    • 12.4.2 Antithrombin Distributors
  • 12.5 Antithrombin Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Antithrombin Industry Trends
  • 13.2 Antithrombin Market Drivers
  • 13.3 Antithrombin Market Challenges
  • 13.4 Antithrombin Market Restraints

14 Key Findings in The Global Antithrombin Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer